ODI Pharma AB (publ) (NGM:ODI)
Sweden · Delayed Price · Currency is SEK 2.260
-0.080 (-3.42%)
At close: Sep 3, 2026
ODI Pharma AB Income Statement
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 32.92 | 3.13 | 22.29 | 0.14 | 0.31 | |
Revenue Growth | 950.33% | -85.94% | 15880.34% | -55.44% | - |
Cost of Revenue | 22.65 | 2.29 | 17.66 | 0.86 | 0.42 |
Gross Profit | 10.27 | 0.84 | 4.62 | -0.72 | -0.1 |
Selling, General & Admin | 7.58 | 6.11 | 6.54 | 6.09 | 7.12 |
Other Operating Expenses | 0.18 | 0.18 | -2.35 | -0 | -0.02 |
Operating Expenses | 7.76 | 6.29 | 4.19 | 6.09 | 7.1 |
Operating Income | 2.5 | -5.45 | 0.43 | -6.81 | -7.21 |
Interest Expense | -0.6 | -0.74 | -0.86 | -0.11 | -0.03 |
Interest & Investment Income | 0.09 | 0.26 | 0.05 | 0.02 | 0 |
Other Non Operating Income (Expenses) | -0 | 0 | - | - | - |
Pretax Income | 1.99 | -5.93 | -0.38 | -6.9 | -7.24 |
Income Tax Expense | 0 | 0 | 0.19 | 0.01 | 0 |
Net Income | 1.99 | -5.93 | -0.57 | -6.9 | -7.24 |
Net Income to Common | 1.99 | -5.93 | -0.57 | -6.9 | -7.24 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 18 | 19 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 18 | 19 | 15 | 15 | 15 |
Shares Change | -1.14% | 21.82% | -0.76% | 1.69% | -1.52% |
EPS (Basic) | 0.11 | -0.32 | -0.04 | -0.45 | -0.48 |
EPS (Diluted) | 0.11 | -0.32 | -0.04 | -0.45 | -0.48 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 4.58 | -3.31 | -3.82 | -5.1 | -7.38 |
Free Cash Flow Per Share | 0.25 | -0.18 | -0.25 | -0.33 | -0.49 |
Gross Margin | 31.20% | 26.77% | 20.74% | - | -33.12% |
Operating Margin | 7.61% | -173.94% | 1.92% | -4884.20% | -2302.98% |
Profit Margin | 6.04% | -189.33% | -2.55% | -4948.58% | -2313.25% |
Free Cash Flow Margin | 13.90% | -105.49% | -17.16% | -3659.83% | -2357.80% |
EBITDA | 2.51 | -5.45 | 0.43 | -6.81 | -7.2 |
EBITDA Margin | 7.62% | -173.88% | 1.93% | - | - |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 |
EBIT | 2.5 | -5.45 | 0.43 | -6.81 | -7.21 |
EBIT Margin | 7.61% | -173.94% | 1.92% | - | - |
Effective Tax Rate | 0.00% | - | - | - | - |
Revenue as Reported | 33.47 | 3.45 | 25.33 | 0.18 | 0.4 |